Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 14, 2022Open Access

Lower Risk of Multisystem Inflammatory Syndrome in Children (MIS-C) with the Delta and Omicron variants of SARS-CoV-2

View Full Paper
Ask AI
Bookmark
Share

Authors

JCJonathan CohenBrighton and Sussex Medical SchoolMCMichael J. CarterCalifornia State University, NorthridgeRCRonny CheungKing's College London

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Cohen et al. (2022) studied this question.

synapsesocial.com/papers/6ab6220c8f558a45c0195d5ehttps://doi.org/10.1101/2022.03.13.22272267
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Incidence of Multisystem Inflammatory Syndrome in Children Among US Persons Infected With SARS-CoV-22021 · 407 citations
  2. 2Multisystem inflammatory syndrome in children occurred in one of four thousand children with severe acute respiratory syndrome coronavirus 22021 · 47 citations
  3. 3Adolescent vaccination with BNT162b2 (Comirnaty, Pfizer-BioNTech) vaccine and effectiveness against COVID-19: national test-negative case-control study, England2021 · 16 citations
  4. 4Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA Vaccination Against Multisystem Inflammatory Syndrome in Children Among Persons Aged 12–18 Years — United States, July–December 20212022 · 289 citations